February 22, 2024
You are here:  Home  >  Banking & Finance  >  Current Article

Amgen goes full speed ahead on biosimilar drugs


Health care costs in the United States are among the highest in the world. In 2019, a national health expenditures report found that the U.S. spent nearly $3.8 trillion in healthcare costs, a problem only exacerbated by the COVID-19 pandemic. One way the biotechnology industry is trying to tackle the problem is the emergence of…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.